Welcome to our dedicated page for Palomar Holdings SEC filings (Ticker: PLMR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Palomar Holdings, Inc. (NASDAQ: PLMR), a specialty property and casualty insurance holding company. Through these documents, investors can review Palomar’s regulatory disclosures about its earthquake, inland marine and other property, casualty, fronting, and crop insurance activities, as well as its capital structure and risk profile.
Palomar’s annual reports on Form 10-K and quarterly reports on Form 10-Q typically present detailed information on underwriting results, loss and expense ratios, reinsurance arrangements, investment portfolios, and risk factors. These filings also describe the operations of subsidiaries such as Palomar Specialty Insurance Company (PSIC), Palomar Specialty Reinsurance Company Bermuda Ltd. (PSRE), Palomar Excess and Surplus Insurance Company (PESIC), First Indemnity of America Insurance Co. (FIA), and Palomar Crop Insurance Services, Inc. (PCIS), along with the inclusion of Laulima Exchange as a variable interest entity.
Current reports on Form 8-K are especially relevant for tracking material events. Recent 8-Ks have covered the release of quarterly financial results, the approval of a share repurchase program authorizing repurchases of Palomar’s common stock over a multi-year period, and the entry into a material definitive agreement to acquire The Gray Casualty & Surety Company for a specified cash purchase price subject to customary adjustments and regulatory approvals. These filings often include or reference press releases that provide additional context and numerical detail.
Investors interested in insider and executive activity can review Forms 3, 4, and 5 (when available) for information on equity ownership changes and transactions by directors, officers, and significant shareholders. Proxy statements and related filings provide further detail on governance, board composition, and executive compensation.
On Stock Titan, Palomar’s SEC filings are updated in near real time as they are posted to the SEC’s EDGAR system. AI-powered summaries help explain lengthy documents such as 10-Ks and 10-Qs by highlighting key sections on underwriting performance, catastrophe exposure, reinsurance structures, non-GAAP metrics like adjusted net income and adjusted combined ratio, and material corporate actions. This allows users to quickly understand the implications of new filings without reading every page, while still having direct access to the full original documents for deeper analysis.
Palomar Holdings, Inc. (PLMR) submitted a Form 144 disclosing a proposed sale of 612 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ with an aggregate market value of $74,444. The filing shows 26,777,198 shares outstanding, placing this proposed sale at a de minimis percentage of the float.
The securities to be sold were recorded as acquired on 08/18/2025 as restricted stock (amount acquired: 1,020 shares) with the nature of payment listed as compensation. The filing also discloses a recent sale of 521 shares by Jon Christianson on 05/18/2025 for $82,855. The notice includes the seller's representation that no undisclosed material adverse information exists.
Form 4 summary: Martha Notaras, a Director of Palomar Holdings, Inc. (PLMR), purchased 100 shares of common stock on 08/07/2025 at $119.915 per share. Following the transaction she beneficially owns 7,870 shares held directly. Reporting address: 7979 Ivanhoe Avenue, Suite 500, La Jolla, CA 92037. Form signed by Angela Grant, Attorney-in-Fact on 08/08/2025.
Palomar Holdings, Inc. (PLMR) filed a Form 144 indicating an insider’s intent to sell up to 1,841 common shares through Morgan Stanley Smith Barney. Based on the stated aggregate market value of $242,641, the proposed sale represents roughly 0.007 % of the company’s 26.7 million shares outstanding, a de-minimis stake unlikely to influence ownership structure or trading liquidity. The shares derive from restricted stock granted as compensation; no cash purchase was involved. The filer reports no other sales in the past three months and affirms no knowledge of undisclosed material information. The anticipated sale date is 31 Jul 2025 on Nasdaq.
Because Form 144 is only a notice, the transaction may or may not occur, and it does not disclose the seller’s identity. Nonetheless, it flags potential insider supply in the market. Given the small size relative to float and absence of adverse disclosures, market impact is expected to be minimal.